Crohn's Disease Clinical Trials in New York

Showing 101-120 of 138 trials

Fecal Calprotectin Collection Protocol

NCT03143517

The primary objective is to obtain stool samples from subjects diagnosed with , and displaying signs and/or symptoms of IBD and/or IBS will be evaluated in this study. Eligible subjects require a diagnostic colonoscopy with possible biopsy and clinical evaluation.

Inflammatory Bowel DiseasesIrritable Bowel SyndromeUlcerative Colitis+10 more

DiaSorin Inc.240 participantsStarted Apr 2017

Dothan, Alabama, United States • Little Rock, Arkansas, United States • Mission Hills, California, United States +10 more locations

COMPLETEDPhase 1< 1 mile

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

NCT02367183

This study is design to explore the effect of GED-0301 on clinical and endoscopic outcome and to evaluate its safety in subjects with active Crohn's disease.

Crohn Disease

Celgene64 participantsStarted Apr 2015

Los Angeles, California, United States • Newport Beach, California, United States • San Diego, California, United States +47 more locations

Fecal Calprotectin Collection Protocol

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

Crohn's Disease Trials in Other Cities

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

Surgical Decision Making Among People With Inflammatory Bowel Disease

To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease

The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers

Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease

The Impact of Vitamin D on Disease Activity in Crohn's Disease

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

Other Conditions in New York